Aileen O'Gorman is a Professor of Substance Use and Social Policy and Director of the UWS Centre for Social, Health and Environmental Inequalities Research (SHEIR). She holds dual appointments at the University of the West of Scotland and the European Union Drugs Agency (EUDA), where she leads the Working Group on Social Determinants of Drug Use (2023–present). Additionally, she serves as a Trustee of the International Society for the Study of Drugs Policy (ISSDP) and on the Board of the Scottish Drugs Forum (2017–present). Her roles also include Honorary Public Health Specialist at NHS Highland (2019–2022) and membership in the international editorial board of Drugs: Education, Prevention and Policy (2012–present). Education: Aileen holds a BA, MSc, and PhD. Her academic career includes prior roles such as Lecturer and Co-ordinator at University College Dublin (UCD), senior researcher at Ireland's National Advisory Committee on Drugs, and community research roles in Dublin and London. Research interests center on the social, structural, and systemic determinants of health inequalities. She focuses on drug-related harms in marginalized communities, participatory research methodologies, and policy impact. Her work addresses issues like poverty, harm reduction strategies, and aligns with UN Sustainable Development Goals. She collaborates with experts by experience, civil society organizations, policymakers, and practitioners to ensure equitable and accessible policy interventions. Her recent funded research includes studies on polydrug use (Chief Scientist Office), primary care's role in preventing drug deaths (Scottish Government), and social autopsies of drug-related deaths (Corra Foundation). She has a history of securing national and international grants for knowledge exchange and policy-oriented studies. Teaching: She leads postgraduate modules in Understanding Substance Use, Politics of Drug Policy, Drugs and Culture, and the MSc CDAS Dissertation. Her pedagogical approach integrates community-based third-sector experience, government collaboration, and international research insights. External collaborations span organizations like the European Union Drugs Agency, Drugs Research Network Scotland, and Scottish Drugs Policy Conversations Steering Group. Her work emphasizes global and local partnerships to address systemic inequities.










